Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
$30.2M | -$0.02 | 104.85% | -78.07% | $3.16 |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | -- |
|
HEAL.CX
|
-- | -- | -- | -- | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-- | -- | -- | -- | -- |
|
WELL.TO
WELL Health Technologies Corp.
|
$368.1M | $0.10 | 99.35% | -77.88% | $7.65 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
$0.88 | $3.16 | $272.1M | -- | $0.00 | 0% | 1.78x |
|
COOL.CX
Core One Labs, Inc.
|
$0.15 | -- | $6.8M | -- | $0.00 | 0% | 32.71x |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
HEAL.CX
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
$0.0250 | -- | $256.9K | 0.65x | $0.00 | 0% | -- |
|
WELL.TO
WELL Health Technologies Corp.
|
$3.92 | $7.65 | $995.2M | 41.90x | $0.00 | 0% | 0.82x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
42.38% | -2.696 | 20.26% | 0.62x |
|
COOL.CX
Core One Labs, Inc.
|
-- | 0.000 | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | 0.000 | -- | -- |
|
HEAL.CX
|
-- | 0.000 | -- | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-3.43% | 1.456 | 20.53% | 0.00x |
|
WELL.TO
WELL Health Technologies Corp.
|
42.5% | -0.072 | 42.92% | 0.83x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
$10M | -$8.6M | -27.67% | -43.62% | -28.31% | -$11.8M |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- | -- | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | -- | -- |
|
HEAL.CX
|
-- | -- | -- | -- | -- | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-- | -$72.1K | -- | -- | -- | -$92.1K |
|
WELL.TO
WELL Health Technologies Corp.
|
$139.3M | $33.3M | -4.02% | -6.26% | 9.13% | $19.2M |
Core One Labs, Inc. has a net margin of -52.71% compared to HealWELL AI, Inc.'s net margin of --. HealWELL AI, Inc.'s return on equity of -43.62% beat Core One Labs, Inc.'s return on equity of --.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
33.01% | -$0.12 | $212.6M |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- |
HealWELL AI, Inc. has a consensus price target of $3.16, signalling upside risk potential of 285.81%. On the other hand Core One Labs, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that HealWELL AI, Inc. has higher upside potential than Core One Labs, Inc., analysts believe HealWELL AI, Inc. is more attractive than Core One Labs, Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
7 | 0 | 0 |
|
COOL.CX
Core One Labs, Inc.
|
0 | 0 | 0 |
HealWELL AI, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Core One Labs, Inc. has a beta of 0.495, suggesting its less volatile than the S&P 500 by 50.458%.
HealWELL AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Core One Labs, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealWELL AI, Inc. pays -- of its earnings as a dividend. Core One Labs, Inc. pays out -- of its earnings as a dividend.
HealWELL AI, Inc. quarterly revenues are $30.4M, which are larger than Core One Labs, Inc. quarterly revenues of --. HealWELL AI, Inc.'s net income of -$16M is higher than Core One Labs, Inc.'s net income of --. Notably, HealWELL AI, Inc.'s price-to-earnings ratio is -- while Core One Labs, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealWELL AI, Inc. is 1.78x versus 32.71x for Core One Labs, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
1.78x | -- | $30.4M | -$16M |
|
COOL.CX
Core One Labs, Inc.
|
32.71x | -- | -- | -- |
Biocure Technology has a net margin of -52.71% compared to HealWELL AI, Inc.'s net margin of --. HealWELL AI, Inc.'s return on equity of -43.62% beat Biocure Technology's return on equity of --.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
33.01% | -$0.12 | $212.6M |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- |
HealWELL AI, Inc. has a consensus price target of $3.16, signalling upside risk potential of 285.81%. On the other hand Biocure Technology has an analysts' consensus of -- which suggests that it could fall by --. Given that HealWELL AI, Inc. has higher upside potential than Biocure Technology, analysts believe HealWELL AI, Inc. is more attractive than Biocure Technology.
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
7 | 0 | 0 |
|
CURE.X.CX
Biocure Technology
|
0 | 0 | 0 |
HealWELL AI, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Biocure Technology has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
HealWELL AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biocure Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealWELL AI, Inc. pays -- of its earnings as a dividend. Biocure Technology pays out -- of its earnings as a dividend.
HealWELL AI, Inc. quarterly revenues are $30.4M, which are larger than Biocure Technology quarterly revenues of --. HealWELL AI, Inc.'s net income of -$16M is higher than Biocure Technology's net income of --. Notably, HealWELL AI, Inc.'s price-to-earnings ratio is -- while Biocure Technology's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealWELL AI, Inc. is 1.78x versus -- for Biocure Technology. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
1.78x | -- | $30.4M | -$16M |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- |
has a net margin of -52.71% compared to HealWELL AI, Inc.'s net margin of --. HealWELL AI, Inc.'s return on equity of -43.62% beat 's return on equity of --.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
33.01% | -$0.12 | $212.6M |
|
HEAL.CX
|
-- | -- | -- |
HealWELL AI, Inc. has a consensus price target of $3.16, signalling upside risk potential of 285.81%. On the other hand has an analysts' consensus of -- which suggests that it could fall by --. Given that HealWELL AI, Inc. has higher upside potential than , analysts believe HealWELL AI, Inc. is more attractive than .
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
7 | 0 | 0 |
|
HEAL.CX
|
0 | 0 | 0 |
HealWELL AI, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
HealWELL AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealWELL AI, Inc. pays -- of its earnings as a dividend. pays out -- of its earnings as a dividend.
HealWELL AI, Inc. quarterly revenues are $30.4M, which are larger than quarterly revenues of --. HealWELL AI, Inc.'s net income of -$16M is higher than 's net income of --. Notably, HealWELL AI, Inc.'s price-to-earnings ratio is -- while 's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealWELL AI, Inc. is 1.78x versus -- for . Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
1.78x | -- | $30.4M | -$16M |
|
HEAL.CX
|
-- | -- | -- | -- |
NanoSphere Health Sciences, Inc. has a net margin of -52.71% compared to HealWELL AI, Inc.'s net margin of --. HealWELL AI, Inc.'s return on equity of -43.62% beat NanoSphere Health Sciences, Inc.'s return on equity of --.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
33.01% | -$0.12 | $212.6M |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-- | -$0.00 | -$1.8M |
HealWELL AI, Inc. has a consensus price target of $3.16, signalling upside risk potential of 285.81%. On the other hand NanoSphere Health Sciences, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that HealWELL AI, Inc. has higher upside potential than NanoSphere Health Sciences, Inc., analysts believe HealWELL AI, Inc. is more attractive than NanoSphere Health Sciences, Inc..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
7 | 0 | 0 |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
0 | 0 | 0 |
HealWELL AI, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NanoSphere Health Sciences, Inc. has a beta of 0.627, suggesting its less volatile than the S&P 500 by 37.292%.
HealWELL AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NanoSphere Health Sciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealWELL AI, Inc. pays -- of its earnings as a dividend. NanoSphere Health Sciences, Inc. pays out -- of its earnings as a dividend.
HealWELL AI, Inc. quarterly revenues are $30.4M, which are larger than NanoSphere Health Sciences, Inc. quarterly revenues of --. HealWELL AI, Inc.'s net income of -$16M is lower than NanoSphere Health Sciences, Inc.'s net income of -$13.1K. Notably, HealWELL AI, Inc.'s price-to-earnings ratio is -- while NanoSphere Health Sciences, Inc.'s PE ratio is 0.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealWELL AI, Inc. is 1.78x versus -- for NanoSphere Health Sciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
1.78x | -- | $30.4M | -$16M |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-- | 0.65x | -- | -$13.1K |
WELL Health Technologies Corp. has a net margin of -52.71% compared to HealWELL AI, Inc.'s net margin of -0.73%. HealWELL AI, Inc.'s return on equity of -43.62% beat WELL Health Technologies Corp.'s return on equity of -6.26%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
33.01% | -$0.12 | $212.6M |
|
WELL.TO
WELL Health Technologies Corp.
|
38.19% | $0.02 | $1.6B |
HealWELL AI, Inc. has a consensus price target of $3.16, signalling upside risk potential of 285.81%. On the other hand WELL Health Technologies Corp. has an analysts' consensus of $7.65 which suggests that it could grow by 95.15%. Given that HealWELL AI, Inc. has higher upside potential than WELL Health Technologies Corp., analysts believe HealWELL AI, Inc. is more attractive than WELL Health Technologies Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
7 | 0 | 0 |
|
WELL.TO
WELL Health Technologies Corp.
|
8 | 0 | 0 |
HealWELL AI, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison WELL Health Technologies Corp. has a beta of 1.234, suggesting its more volatile than the S&P 500 by 23.424%.
HealWELL AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. WELL Health Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealWELL AI, Inc. pays -- of its earnings as a dividend. WELL Health Technologies Corp. pays out -- of its earnings as a dividend.
HealWELL AI, Inc. quarterly revenues are $30.4M, which are smaller than WELL Health Technologies Corp. quarterly revenues of $364.6M. HealWELL AI, Inc.'s net income of -$16M is lower than WELL Health Technologies Corp.'s net income of -$2.7M. Notably, HealWELL AI, Inc.'s price-to-earnings ratio is -- while WELL Health Technologies Corp.'s PE ratio is 41.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealWELL AI, Inc. is 1.78x versus 0.82x for WELL Health Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
AIDX.TO
HealWELL AI, Inc.
|
1.78x | -- | $30.4M | -$16M |
|
WELL.TO
WELL Health Technologies Corp.
|
0.82x | 41.90x | $364.6M | -$2.7M |
Signup to receive the latest stock alerts
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Market Cap: $4.5T
P/E Ratio: 63x
Market Cap: $4T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
UniFirst Corp. [UNF] is up 0.77% over the past day.